The AI Infusion: How Pharma Titans Eli Lilly and Johnson & Johnson Are Teaming Up with NVIDIA to Reshape Medicine

The Looming Dawn of a New Era: How NVIDIA's Vision Is Quietly Reshaping Every Industry

Tylenol in the Crosshairs: Texas Families Seek Answers on Autism Allegations

The Quiet Hum of September's Dividends: A Steady Path to Financial Resilience

A Remarkable Re-Entry: How GSK's Blenrep Battled Back for a Second Shot at Fighting Myeloma

The Intelligent Pivot: How Savvy Acquisitions Are Forging a New Path to Profitability

The Dow's High Flyers: Can Earnings Sustain the Momentum?

Navigating the Paradox: Why Genmab's Stock Dipped Despite Positive News for its Key Partnership

Carvykti's Q3 Performance: Legend Biotech Navigates Sales Landscape

Johnson & Johnson Soars: Beating Q3 Expectations and Raising Full-Year Outlook

Healthcare Giants Soar: Novo Nordisk, Bristol Myers Squibb, and J&J Lead the Week's Breakthroughs

A Pivotal Moment: HHS Advances Major Drug Pricing Rule for Review

Unleash the Alpha: Why This October Dog of the Dow is a Top Dividend Pick

Pharma's Big Win: How a Judge's Ruling Ignited Big Pharma Stocks

Trump's Bold Play: Delaying Pharma Tariffs for Deeper Drug Price Deals

Trump's Bold Vision: Pushing for Direct Drug Deals to Slash Costs

IG Acquisition Corp. (IGAC): The Power of a Vanishing Discount Fueling Stellar Returns

Historic Shift: White House Reviews Landmark Drug Price Negotiation Rule

Healthcare Shorts Take a Breather, But Moderna Remains Under the Microscope

Kenvue Explores 'Learned Intermediary' Defense Amidst Thousands of Tylenol-Autism Lawsuits

Controversial Critic Returns: Dr. Vinay Prasad Reassumes Key FDA Role

A New Horizon in Bladder Cancer Treatment: J&J's Balversa Secures Full FDA Approval

Game Changer: FDA Approves Johnson & Johnson's TAR-200 for High-Risk Bladder Cancer

Trump's Biotech Revolution: Unleashing a Staggering $350 Billion Investment Wave

Legend Biotech Explores Strategic Second Listing Beyond US Shores

Amneal Pharmaceuticals Secures Landmark FDA Approval for Generic Risperdal Consta

Carlsmed's Personalized Spine Implants Revolutionize Care with Landmark Reimbursement Approval